This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Attention Deficit Disorder With Hyperactivity
and you are
between 7 and 12
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study is to find out if children with attention-deficit, hyperactivity disorder (ADHD) have a difference in how their brain cells "fire" or react. The investigators also want to find if brain cell "firing" can tell us how severe of symptoms a child has from ADHD. Finally, the investigators want to see if giving an ADHD medication called atomoxetine can make the ADHD symptoms in a child better and if the improvement shows a change in brain "firing".

Provided treatments

  • Drug: Atomoxetine
  • Drug: Sugar Pill

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01330693. The sponsor of the trial is University of Cincinnati and it is looking for 120 volunteers for the current phase.
Official trial title:
Cortical Excitability: Phenotype and Biomarker in ADHD Therapy